Literature DB >> 2541037

Structural basis of beta-adrenergic receptor function.

C D Strader1, I S Sigal, R A Dixon.   

Abstract

Receptors that mediate their actions by stimulating guanine nucleotide binding regulatory proteins (G proteins) share structural as well as functional similarities. The structural motif characteristic of receptors of this class includes seven hydrophobic putative transmembrane domains linked by hydrophilic loops. Genetic analysis of the beta-adrenergic receptor (beta AR) revealed that the ligand binding domain of this receptor, like that of rhodopsin, involves residues within the hydrophobic core of the protein. On the basis of these studies, a model for ligand binding to the receptor has been developed in which the amino group of an agonist or antagonist is anchored to the receptor through the carboxylate side chain of Asp113 in the third transmembrane helix. Other interactions between specific residues of the receptor and functional groups on the ligand have also been proposed. The interaction between the beta AR and the G protein Gs has been shown to involve an intracellular region that is postulated to form an amphiphilic alpha helix. This region of the beta AR is also critical for sequestration, which accompanies agonist-mediated desensitization, to occur. Structural similarities among G protein-linked receptors suggest that the information gained from the genetic analysis of the beta AR should help define functionally important regions of other receptors of this class.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2541037     DOI: 10.1096/fasebj.3.7.2541037

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  72 in total

1.  Disparate ligand-mediated Ca(2+) responses by wild-type, mutant Ser(200)Ala and Ser(204)Ala alpha(2A)-adrenoceptor: G(alpha15) fusion proteins: evidence for multiple ligand-activation binding sites.

Authors:  P J Pauwels; F C Colpaert
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

2.  Molecular mechanisms underlying differential odor responses of a mouse olfactory receptor.

Authors:  W B Floriano; N Vaidehi; W A Goddard; M S Singer; G M Shepherd
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

3.  The variable and conserved interfaces of modeled olfactory receptor proteins.

Authors:  Y Pilpel; D Lancet
Journal:  Protein Sci       Date:  1999-05       Impact factor: 6.725

4.  Strategies for the determination of pharmacophoric 3D database queries.

Authors:  J H Van Drie
Journal:  J Comput Aided Mol Des       Date:  1997-01       Impact factor: 3.686

5.  The extracellular domain of substance P (NK1) receptor comprises part of the ligand binding site.

Authors:  T M Fong; H Yu; C D Strader
Journal:  Biophys J       Date:  1992-04       Impact factor: 4.033

6.  Molecular modelling of D2-like dopamine receptors.

Authors:  C D Livingstone; P G Strange; L H Naylor
Journal:  Biochem J       Date:  1992-10-01       Impact factor: 3.857

Review 7.  Receptors and transduction mechanisms in anterior pituitary: primary cultures, transfected clonal cells and human tumor derived cells.

Authors:  A Enjalbert
Journal:  Cell Biol Toxicol       Date:  1992 Jul-Sep       Impact factor: 6.691

Review 8.  In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors.

Authors:  T M Savarese; C M Fraser
Journal:  Biochem J       Date:  1992-04-01       Impact factor: 3.857

9.  On the use of the transmembrane domain of bacteriorhodopsin as a template for modeling the three-dimensional structure of guanine nucleotide-binding regulatory protein-coupled receptors.

Authors:  L Pardo; J A Ballesteros; R Osman; H Weinstein
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

10.  Two members of a distinct subfamily of 5-hydroxytryptamine receptors differentially expressed in rat brain.

Authors:  M G Erlander; T W Lovenberg; B M Baron; L de Lecea; P E Danielson; M Racke; A L Slone; B W Siegel; P E Foye; K Cannon
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.